ABL1 and Alzheimer disease: Altogether, the data presented here indicate that treating an animal model of AD with high brain penetrant c-Abl inhibitor neurotinib improves memory performance in a hippocampus-dependent task, replicating the same pattern observed in the AD mice model knock-out for c-Abl.